62
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis

, , , , , , , , & show all
Pages 25-30 | Published online: 14 Jan 2013

References

  • LeeDMWeinblattMERheumatoid arthritisLancet200135890391111567728
  • JenkinsJKHardyKJMcMurrayRWThe pathogenesis of rheumatoid arthritis: a guide to therapyAm J Med Sci2002323417118012003371
  • ScottDLWolfeFHuizingaTWRheumatoid arthritisLancet201037697461094110820870100
  • WelsingPMvan GestelAMSwinkelsHLKiemeneyLAvan RielPLThe relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritisArthritis Rheum20014492009201711592361
  • HarrimanGHarperLKSchaibleTFSummary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatmentAnn Rheum Dis199958 Suppl 1161164
  • GarrisonLMcDonnellNDEtanercept: therapeutic use in patients with rheumatoid arthritisAnn Rheum Dis199958 Suppl 1165169
  • PincusTCallahanLFSaleWGBrooksALPayneLEVaughnWKSevere functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine yearsArthritis Rheum19842788648726431998
  • YelinEHenkeCEpsteinWThe work dynamics of the person with rheumatoid arthritisArthritis Rheum19873055075123593434
  • WolfeFHawleyDJThe longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patientsJ Rheumatol19982511210821179818651
  • StrandVKhannaDThe impact of rheumatoid arthritis and treatment on patients’ livesClin Exp Rheumatol2010283 Suppl 59S32S4020576223
  • FautrelBWoronoff-LemsiMCEthgenMImpact of medical practices on the costs of management of rheumatoid arthritis by anti-TNFalpha biological therapy in FranceJoint Bone Spine200572655055615996504
  • LaasKPeltomaaRKautiainenHPuolakkaKLeirisalo-RepoMPharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatmentAnn Rheum Dis200665792492816339293
  • ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum19883133153243358796
  • van der HeijdeDMvan‘t HofMAvan RielPLJudging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity scoreAnn Rheum Dis199049119169202256738
  • van GestelAMPrevooMLvan‘t HofMAvan RijswijkMHvan de PutteLBvan RielPLDevelopment and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism CriteriaArthritis Rheum199639134408546736
  • PincusTSummeyJASoraciSAJrWallstonKAHummonNPAssessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment QuestionnaireArthritis Rheum19832611134613536639693
  • van der HeijdeDHanCDeVlamKInfliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trialArthritis Rheum200655456957416874778
  • GeuskensGAHazesJMBarendregtPJBurdorfAPredictors of sick leave and reduced productivity at work among persons with early inflammatory joint conditionsScand J Work Environ Health200834642042919137203
  • WolfeFAllaireSMichaudKThe prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disabilityJ Rheumatol200734112211221717787043
  • SmolenJSHanCvan der HeijdeDInfliximab treatment maintains employability in patients with early rheumatoid arthritisArthritis Rheum200654371672216508932
  • KeatACGaffneyKGilbertAKHarrisCLeederJInfluence of biologic therapy on return to work in people with work disability due to ankylosing spondylitisRheumatology (Oxford)200847448148318281690
  • AllaireSWolfeFNiuJZhangYZhangBLaValleyMEvaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still outArthritis Rheum20085981082108918668597
  • BejaranoVQuinnMConaghanPGEffect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritisArthritis Rheum200859101467147418821658
  • RatermanHGHovingJLNurmohamedMTWork ability: a new outcome measure in rheumatoid arthritis?Scand J Rheumatol201039212713120059369
  • KavanaughAAntoniCMeasePEffect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritisJ Rheumatol200633112254225916960923
  • YelinEMeenanRNevittMEpsteinWWork disability in rheumatoid arthritis: effects of disease, social, and work factorsAnn Intern Med19809345515567436187
  • KarassaFBIoannidisJPTouloumiGBokiKAMoutsopoulosHMRisk factors for central nervous system involvement in systemic lupus erythematosusQJM200093316917410751236
  • RatACBoissierMCRheumatoid arthritis: direct and indirect costsJoint Bone Spine200471651852415589432
  • YelinEThe costs of rheumatoid arthritis: absolute, incremental, and marginal estimatesJ Rheumatol Suppl19964447518833052
  • ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics19934535336510146874
  • ReillyMCGoochKLWongRLKupperHvan der HeijdeDValidity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitisRheumatology (Oxford)201049481281920100797
  • ZhangWBansbackNBoonenAYoungASinghAAnisAHValidity of the work productivity and activity impairment questionnaire - general health version in patients with rheumatoid arthritisArthritis Res Ther2010125R17720860837